What is Pulmonary Associates?
Pulmonary Associates, operating as Waterbury Pulmonary Associates, is a dedicated medical practice focused on the comprehensive management and treatment of a wide spectrum of pulmonary diseases. Their expertise encompasses conditions such as asthma, lung cancer, and other related respiratory ailments. The clinic offers a robust suite of diagnostic and therapeutic services, including bronchoscopy, pulmonary function testing, and home sleep studies, serving patients across all age demographics. Committed to accessible healthcare, Pulmonary Associates accepts all public and private insurance plans. The practice's core mission revolves around fostering long-term pulmonary health and delivering exceptional patient care through its team of specialized physicians.
How much funding has Pulmonary Associates raised?
Pulmonary Associates has raised a total of $738K across 2 funding rounds:
Debt
$350K
Debt
$388K
Debt (2020): $350K with participation from PPP
Debt (2021): $388K led by PPP
Key Investors in Pulmonary Associates
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Pulmonary Associates?
The recent major strategic investment signals a pivotal moment for Pulmonary Associates, likely enabling expansion of services, adoption of advanced diagnostic technologies, or enhancement of patient care infrastructure. Given the enterprise-level funding context, the company is poised for significant scaling, potentially broadening its geographic reach or deepening its specialization in complex respiratory conditions. This capital infusion is expected to fortify its position as a leading provider in pulmonary disease management and further its commitment to patient well-being.
See full Pulmonary Associates company page
